Search

Your search keyword '"MASETTI, RICCARDO"' showing total 881 results
Start Over Author "MASETTI, RICCARDO" Publication Type Academic Journals
881 results on '"MASETTI, RICCARDO"'

4. Is CAR T a drug or a therapeutic pathway? Intention to treat versus per protocol analysis of real world studies of CAR-T cell therapy in relapsed refractory diffuse large B cell lymphoma

Author

Di Staso, Rossana, Casadei, Beatrice, Locke, Frederick L., Jain, Michael, Voorhees, Timothy J., Kittai, Adam S., Bastos-Oreiro, Mariana, Gutiérrez, Antonio, Martin Garcia-Sancho, Alejandro, Terol, Maria Jose, Mead, Monica, Maranzano, Michael J., Iacoboni, Gloria, Barba, Pere, Kwon, Mi, Bailen, Rebeca, Reguera-Ortega, Juan Luis, Mian, Agrima, Hill, Brian, Bachy, Emmanuel, Morschhauser, Franck, Houot, Roch, Thieblemont, Catherine, Le Gouill, Steven, Masetti, Riccardo, Gori, Davide, Broccoli, Alessandro, Zinzani, Pier Luigi, and Argnani, Lisa

Published
2024
Full Text
View/download PDF

7. Letermovir for Cytomegalovirus infection in pediatric patients undergoing allogenic hematopoietic stem cell transplantation: a real-life study by the Infectious Diseases Working Group of Italian Association of Pediatric Hematology-Oncology (AIEOP)

Author

Galaverna, Federica, Baccelli, Francesco, Zama, Daniele, Tridello, Gloria, Masetti, Riccardo, Soncini, Elena, Mura, Rossella, Barzaghi, Federica, Colombini, Antonella, Prunotto, Giulia, D’Amico, Maria Rosaria, Calore, Elisabetta, Biffi, Alessandra, Perruccio, Katia, Gasperini, Pietro, Oltolini, Chiara, Quagliarella, Francesco, Giacomazzi, Alice, Pagliara, Daria, Locatelli, Franco, and Cesaro, Simone

Published
2024
Full Text
View/download PDF

8. Current practices for nutritional evaluation and care during the treatment of pediatric oncology patients: a survey among AIEOP centers

Author

Venturelli, Francesco, Leardini, Davide, Baccelli, Francesco, Gottardi, Francesca, Barat, Veronica, Vendemini, Francesca, Folsi, Veronica Maria, Meazza, Cristina, Marinoni, Maddalena, Bernardo, Maria Ester, Tumino, Manuela, Brugiolo, Alessandra, Pizzato, Cristina, Battisti, Laura, Bertolini, Patrizia, Pancaldi, Alessia, Rinieri, Simona, Pericoli, Roberta, Coccia, Paola, Onofrillo, Daniela, Fabozzi, Francesco, Bianchi, Simona, Rizzo, Daniela, Daniele, Rosa Maria, Stellato, Pio, Prete, Arcangelo, Masetti, Riccardo, and Muratore, Edoardo

Published
2024
Full Text
View/download PDF

10. Epilepsy after acute central nervous system complications of pediatric hematopoietic cell transplantation: A retrospective, multicenter study

Author

Bergonzini, Luca, Leardini, Davide, Rao, Roberta, Foiadelli, Thomas, Faraci, Maura, Mancardi, Maria Margherita, Nobile, Giulia, Orsini, Alessandro, Savasta, Salvatore, Gottardi, Francesca, Fetta, Anna, Mina, Tommaso, Casazza, Gabriella, Menconi, Maria Cristina, Pruna, Dario, Mura, Rosa Maria, Piroddi, Antonio, Rucci, Paola, Masetti, Riccardo, and Cordelli, Duccio Maria

Published
2024
Full Text
View/download PDF

11. A Nationwide Study of GATA2 Deficiency in Italy Reveals Novel Symptoms and Genotype–phenotype Association

Author

Roncareggi, Samuele, Girardi, Katia, Fioredda, Francesca, Pedace, Lucia, Arcuri, Luca, Badolato, Raffaele, Bonanomi, Sonia, Borlenghi, Erika, Cirillo, Emilia, Coliva, Tiziana, Consonni, Filippo, Conti, Francesca, Farruggia, Piero, Gambineri, Eleonora, Guerra, Fabiola, Locatelli, Franco, Mancuso, Gaia, Marzollo, Antonio, Masetti, Riccardo, Micalizzi, Concetta, Onofrillo, Daniela, Piccini, Matteo, Pignata, Claudio, Raddi, Marco Gabriele, Santini, Valeria, Vendemini, Francesca, Biondi, Andrea, and Saettini, Francesco

Published
2023
Full Text
View/download PDF

13. Multigenic panels in breast cancer: Clinical utility and management of patients with pathogenic variants other than BRCA1/2

Author

Fabi, Alessandra, Cortesi, Laura, Duranti, Simona, Cordisco, Emanuela Lucci, Di Leone, Alba, Terribile, Daniela, Paris, Ida, de Belvis, Antonio Giulio, Orlandi, Armando, Marazzi, Fabio, Muratore, Margherita, Garganese, Giorgia, Fuso, Paola, Paoletti, Filippo, Dell’Aquila, Rossella, Minucci, Angelo, Scambia, Giovanni, Franceschini, Gianluca, Masetti, Riccardo, and Genuardi, Maurizio

Published
2024
Full Text
View/download PDF

21. Gut microbiota diversity before allogeneic hematopoietic stem cell transplantation as a predictor of mortality in children

Author

Masetti, Riccardo, Leardini, Davide, Muratore, Edoardo, Fabbrini, Marco, D’Amico, Federica, Zama, Daniele, Baccelli, Francesco, Gottardi, Francesca, Belotti, Tamara, Ussowicz, Marek, Fraczkiewicz, Jowita, Cesaro, Simone, Zecca, Marco, Merli, Pietro, Candela, Marco, Pession, Andrea, Locatelli, Franco, Prete, Arcangelo, Brigidi, Patrizia, and Turroni, Silvia

Published
2023
Full Text
View/download PDF

22. Second allogeneic stem cell transplantation can rescue a significant proportion of patients with JMML relapsing after first allograft

Author

Vinci, Luca, Flotho, Christian, Noellke, Peter, Lebrecht, Dirk, Masetti, Riccardo, de Haas, Valerie, De Moerloose, Barbara, Dworzak, Michael, Hasle, Henrik, Güngör, Tayfun, Starý, Jan, Turkiewicz, Dominik, Ussowicz, Marek, de Heredia, Cristina Diaz, Buechner, Jochen, Jahnukainen, Kirsi, Kallay, Krisztian, Bodova, Ivana, Smith, Owen P., Zecca, Marco, Bresters, Dorine, Lang, Peter, Masmas, Tania Nicole, Meisel, Roland, Pichler, Herbert, Erlacher, Miriam, Göhring, Gudrun, Locatelli, Franco, Strahm, Brigitte, Niemeyer, Charlotte M., and Yoshimi, Ayami

Published
2023
Full Text
View/download PDF

23. Long-term proliferation of immature hypoxia-dependent JMML cells supported by a 3D in vitro system

Author

Cani, Alice, Tretti Parenzan, Caterina, Frasson, Chiara, Rampazzo, Elena, Scarparo, Pamela, Francescato, Samuela, Caicci, Federico, Barbieri, Vito, Rosato, Antonio, Cesaro, Simone, Zecca, Marco, Micalizzi, Concetta, Sainati, Laura, Pigazzi, Martina, Biffi, Alessandra, Buldini, Barbara, Locatelli, Franco, Persano, Luca, Masetti, Riccardo, te Kronnie, Geertruij, and Bresolin, Silvia

Published
2023
Full Text
View/download PDF

24. Safety and Efficacy of Ribociclib in Combination with Letrozole in Patients with HR+, HER2− Advanced Breast Cancer: Results from the Italian Subpopulation of Phase 3b CompLEEment-1 Study

Author

De Laurentiis, Michelino, Caputo, Roberta, Mazza, Manuelita, Mansutti, Mauro, Masetti, Riccardo, Ballatore, Zelmira, Torrisi, Rosalba, Michelotti, Andrea, Zambelli, Alberto, Ferro, Antonella, Generali, Daniele, Vici, Patrizia, Coltelli, Luigi, Fabi, Alessandra, Marchetti, Paolo, Ballestrero, Alberto, Spazzapan, Simon, Frassoldati, Antonio, Sarobba, Maria Giuseppina, Grasso, Donatella, and Zamagni, Claudio

Published
2022
Full Text
View/download PDF

26. Hypodiploidy has unfavorable impact on survival in pediatric acute myeloid leukemia: an I-BFM Study Group collaboration

Author

Hammer, Anne Sofie Borg, Juul-Dam, Kristian Løvvik, Sandahl, Julie Damgaard, Abrahamsson, Jonas, Czogala, Malgorzata, Delabesse, Emmanuelle, Haltrich, Iren, Jahnukainen, Kirsi, Kolb, E. Anders, Kovács, Gábor, Leverger, Guy, Locatelli, Franco, Masetti, Riccardo, Noren-Nyström, Ulrika, Raimondi, Susana C., Rasche, Mareike, Reinhardt, Dirk, Taki, Tomohiko, Tomizawa, Daisuke, Zeller, Bernward, Hasle, Henrik, and Kjeldsen, Eigil

Published
2023
Full Text
View/download PDF

28. Antibiotic prophylaxis and management of infections in pediatric hematopoietic stem cell transplantation: a survey from the Stem Cell Transplant and the Infectious Disease Working Groups of the AIEOP network

Author

Zama, Daniele, Masetti, Riccardo, Baccelli, Francesco, Leardini, Davide, Muratore, Edoardo, Abram, Nicoletta, Vendemini, Francesca, Biffi, Alessandra, Perruccio, Katia, D’Amico, Maria Rosaria, Faraci, Maura, Tintori, Veronica, Spirito, Anita, Lo Nigro, Luca, Locatelli, Franco, Luksch, Roberto, Saglio, Francesco, Santoro, Nicola, Soncini, Elena, Zecca, Marco, Ziino, Ottavio, Prete, Arcangelo, Pagliara, Daria, and Cesaro, Simone

Published
2022
Full Text
View/download PDF

30. Identification of a minimum number of genes to predict triple-negative breast cancer subgroups from gene expression profiles

Author

Akhouayri, Laila, Ostano, Paola, Mello-Grand, Maurizia, Gregnanin, Ilaria, Crivelli, Francesca, Laurora, Sara, Liscia, Daniele, Leone, Francesco, Santoro, Angela, Mulè, Antonino, Guarino, Donatella, Maggiore, Claudia, Carlino, Angela, Magno, Stefano, Scatolini, Maria, Di Leone, Alba, Masetti, Riccardo, and Chiorino, Giovanna

Published
2022
Full Text
View/download PDF

32. Clinical evolution, genetic landscape and trajectories of clonal hematopoiesis in SAMD9/SAMD9L syndromes

Author

Sahoo, Sushree S., Pastor, Victor B., Goodings, Charnise, Voss, Rebecca K., Kozyra, Emilia J., Szvetnik, Amina, Noellke, Peter, Dworzak, Michael, Starý, Jan, Locatelli, Franco, Masetti, Riccardo, Schmugge, Markus, De Moerloose, Barbara, Catala, Albert, Kállay, Krisztián, Turkiewicz, Dominik, Hasle, Henrik, Buechner, Jochen, Jahnukainen, Kirsi, Ussowicz, Marek, Polychronopoulou, Sophia, Smith, Owen P., Fabri, Oksana, Barzilai, Shlomit, de Haas, Valerie, Baumann, Irith, Schwarz-Furlan, Stephan, Niewisch, Marena R., Sauer, Martin G., Burkhardt, Birgit, Lang, Peter, Bader, Peter, Beier, Rita, Müller, Ingo, Albert, Michael H., Meisel, Roland, Schulz, Ansgar, Cario, Gunnar, Panda, Pritam K., Wehrle, Julius, Hirabayashi, Shinsuke, Derecka, Marta, Durruthy-Durruthy, Robert, Göhring, Gudrun, Yoshimi-Noellke, Ayami, Ku, Manching, Lebrecht, Dirk, Erlacher, Miriam, Flotho, Christian, Strahm, Brigitte, Niemeyer, Charlotte M., and Wlodarski, Marcin W.

Published
2021
Full Text
View/download PDF

33. Autoimmunity and cancer

Author

Masetti, Riccardo, Tiri, Alessandra, Tignanelli, Anna, Turrini, Elena, Argentiero, Alberto, Pession, Andrea, and Esposito, Susanna

Published
2021
Full Text
View/download PDF

35. Pregnancy-Associated Breast Cancer: A Multidisciplinary Approach

Author

Paris, Ida, Di Giorgio, Danilo, Carbognin, Luisa, Corrado, Giacomo, Garganese, Giorgia, Franceschini, Gianluca, Sanchez, Alejandro Martin, De Vincenzo, Rosa Pasqualina, Accetta, Cristina, Terribile, Daniela Andreina, Magno, Stefano, Di Leone, Alba, Bove, Sonia, Masetti, Riccardo, and Scambia, Giovanni

Published
2021
Full Text
View/download PDF

36. Posterior Reversible Encephalopathy Syndrome in infants and young children

Author

Cordelli, Duccio Maria, Marra, Chiara, Ciampoli, Lara, Barbon, Davide, Toni, Francesco, Zama, Daniele, Giordano, Lucio, Milito, Giuseppe, Sartori, Stefano, Sainati, Laura, Foiadelli, Thomas, Mina, Tommaso, Fusco, Lucia, Santarone, Marta, Iurato, Chiara, Orsini, Alessandro, Farello, Giovanni, Verrotti, Alberto, Aceti, Arianna, and Masetti, Riccardo

Published
2021
Full Text
View/download PDF

37. Outcomes of Radiotherapy in Oligoprogressive Breast Cancer.

Author

Marazzi, Fabio, Masiello, Valeria, Orlandi, Armando, Moschella, Francesca, Chiesa, Silvia, Di Leone, Alba, Garufi, Giovanna, Mazzarella, Ciro, Sanchez, Alejandro M., Casa, Calogero, Bucaro, Angela, De Lauretis, Flavia, Borghesan, Niccolo, Tagliaferri, Luca, Franceschini, Gianluca, Bria, Emilio, Masetti, Riccardo, Fabi, Alessandra, Aristei, Cynthia, and Tortora, Giampaolo

Subjects
METASTATIC breast cancer, OVERALL survival, MULTIVARIATE analysis, REGRESSION analysis, PROGRESSION-free survival
Abstract

Introduction: Radiotherapy (RT) shows potential for improving local control in cases of oligoprogressive metastatic breast cancer (mBC). This retrospective analysis aims to evaluate the advantages of RT in such a clinical scenario. Methods: We conducted a retrospective analysis including patients with mBC who received radiation therapy (RT) for up to three sites of oligoprogression while continuing systemic therapy. The study took place between January 2014 and December 2021. Our endpoints were progression-free survival after radiotherapy (PFS-AR), the rate of discontinuation of systemic therapy (RDT) at three months post-RT, and overall survival (OS). We used Cox regression analysis to perform multivariate analysis for PFS-AR. Results: Fifty-nine patients met the inclusion criteria. The PFS-AR was 13 months (95% CI 8.5–18.8 months). At three months, the RDT was 3% (two patients). A significant difference in median PFS-AR was observed between patients in the first + second-line group and those in the subsequent line group (p = 0.03). In the multivariate analysis conducted for PFS-AR, the biologically effective dose (BED) with α/β = 4 > 100 Gy emerged as the sole significant variable (p = 0.0017). The median overall survival (OS) was 24.4 months (95% CI 17–24.4 months). Conclusions: This study is the first report on the outcomes of radiotherapy in a cohort of over 50 patients with oligoprogressive metastatic breast cancer (mBC). Our findings emphasize the significant relationship between PFS-AR, the number of ongoing lines of systemic therapy, and the BED of radiotherapy. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

38. Impact of Inflammatory Burden on Voriconazole Exposure in Oncohematological Pediatric Patients Receiving Antifungal Prophylaxis after Allogeneic HCT.

Author

Gatti, Milo, Campoli, Caterina, Muratore, Edoardo, Belotti, Tamara, Masetti, Riccardo, Lanari, Marcello, Viale, Pierluigi, and Pea, Federico

Subjects
HEMATOPOIETIC stem cell transplantation, DRUG monitoring, DRUG dosage, BLOOD proteins, CHILD patients
Abstract

(1) Background: The impact of inflammation on voriconazole exposure in oncohematological pediatric patients represents a debated issue. We aimed to investigate the impact of serum C-reactive protein (CRP), procalcitonin (PCT), and interleukin-6 (IL-6) levels on voriconazole exposure in oncohematological pediatric patients requiring allogeneic hematopoietic stem cell transplantation (HCT). (2) Methods: Pediatric patients undergoing allogeneic HCT and receiving therapeutic drug monitoring (TDM)-guided voriconazole as primary antifungal prophylaxis between January 2021 and December 2023 were included. The ratio between concentration and dose (C/D) of voriconazole was used as a surrogate marker of total clearance. A receiving operating characteristic curve analysis was performed by using CRP, PCT, or IL-6 values as the test variable and voriconazole C/D ratio > 0.188 or >0.375 (corresponding to a trough concentration value [Cmin] of 3 mg/L normalized to the maintenance dose of 16 mg/kg/day in patients of age < 12 years and of 8 mg/kg/day in those ≥12 years, respectively) as the state variable. Area under the curve (AUC) and 95% confidence interval (CI) were calculated. (3) Results: Overall, 39 patients were included. The median (IQR) voriconazole Cmin was 1.7 (0.7–3.0) mg/L. A CRP value > 8.49 mg/dL (AUC = 0.72; 95%CI 0.68–0.76; p < 0.0001), a PCT value > 2.6 ng/mL (AUC = 0.71; 95%CI 0.63–0.77; p < 0.0001), and an IL-6 value > 27.9 pg/mL (AUC = 0.80; 95%CI 0.71–0.88; p < 0.0001) were significantly associated with voriconazole overexposure. Consistent results were found in patients aged <12 and ≥12 years. (4) Conclusions: A single specific threshold of inflammatory biomarkers may be linked to a significantly higher risk of voriconazole exposure in oncohematological pediatric patients after HCT, irrespective of age. Adopting a TDM-guided strategy could be useful for minimizing the risk of voriconazole overexposure. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

39. Oncotype DX Predictive Nomogram for Recurrence Score Output: The Novel System ADAPTED01 Based on Quantitative Immunochemistry Analysis

Author

Marazzi, Fabio, Barone, Roberto, Masiello, Valeria, Magri, Valentina, Mulè, Antonino, Santoro, Angela, Cacciatori, Federica, Boldrini, Luca, Franceschini, Gianluca, Moschella, Francesca, Naso, Giuseppe, Tomao, Silverio, Gambacorta, Maria Antonietta, Mantini, Giovanna, Masetti, Riccardo, Smaniotto, Daniela, and Valentini, Vincenzo

Published
2020
Full Text
View/download PDF

40. Synonymous GATA2 mutations result in selective loss of mutated RNA and are common in patients with GATA2 deficiency

Author

Kozyra, Emilia J., Pastor, Victor B., Lefkopoulos, Stylianos, Sahoo, Sushree S., Busch, Hauke, Voss, Rebecca K., Erlacher, Miriam, Lebrecht, Dirk, Szvetnik, Enikoe A., Hirabayashi, Shinsuke, Pasaulienė, Ramunė, Pedace, Lucia, Tartaglia, Marco, Klemann, Christian, Metzger, Patrick, Boerries, Melanie, Catala, Albert, Hasle, Henrik, de Haas, Valerie, Kállay, Krisztián, Masetti, Riccardo, De Moerloose, Barbara, Dworzak, Michael, Schmugge, Markus, Smith, Owen, Starý, Jan, Mejstrikova, Ester, Ussowicz, Marek, Morris, Emma, Singh, Preeti, Collin, Matthew, Derecka, Marta, Göhring, Gudrun, Flotho, Christian, Strahm, Brigitte, Locatelli, Franco, Niemeyer, Charlotte M., Trompouki, Eirini, and Wlodarski, Marcin W.

Published
2020
Full Text
View/download PDF

43. Criteria for evaluating response and outcome in clinical trials for children with juvenile myelomonocytic leukemia

Author

Niemeyer, Charlotte M, Loh, Mignon L, Cseh, Annamaria, Cooper, Todd, Dvorak, Christopher C, Chan, Rebecca, Xicoy, Blanca, Germing, Ulrich, Kojima, Seiji, Manabe, Atsushi, Dworzak, Michael, De Moerloose, Barbara, Starý, Jan, Smith, Owen P, Masetti, Riccardo, Catala, Albert, Bergstraesser, Eva, Ussowicz, Marek, Fabri, Oskana, Baruchel, André, Cavé, Hélène, Zwaan, Michel, Locatelli, Franco, Hasle, Henrik, van den Heuvel-Eibrink, Marry M, Flotho, Christian, and Yoshimi, Ayami

Subjects
Biomedical and Clinical Sciences, Cardiovascular Medicine and Haematology, Pediatric, Clinical Research, Pediatric Cancer, Hematology, Stem Cell Research, Childhood Leukemia, Orphan Drug, Rare Diseases, Clinical Trials and Supportive Activities, Stem Cell Research - Nonembryonic - Human, Stem Cell Research - Nonembryonic - Non-Human, Cancer, Transplantation, Regenerative Medicine, Blood, Inflammatory and immune system, Child, Clinical Trials as Topic, Combined Modality Therapy, Humans, Leukemia, Myelomonocytic, Juvenile, Neoplasm Recurrence, Local, Practice Guidelines as Topic, Prognosis, Survival Rate, Cardiorespiratory Medicine and Haematology, Immunology, Cardiovascular medicine and haematology
Abstract

Juvenile myelomonocytic leukemia is a rare myeloproliferative disease in young children. While hematopoietic stem cell transplantation remains the only curative therapeutic option for most patients, children with juvenile myelomonocytic leukemia increasingly receive novel agents in phase I-II clinical trials as pre-transplant therapy or therapy for relapse after transplantation. However, response criteria or definitions of outcome for standardized evaluation of treatment effect in patients with juvenile myelomonocytic leukemia are currently lacking. Here we propose criteria to evaluate the response to the non-transplant therapy and definitions of remission status after hematopoietic stem cell transplantation. For the evaluation of non-transplant therapy, we defined 6 clinical variables (white blood cell count, platelet count, hematopoietic precursors and blasts in peripheral blood, bone marrow blast percentage, spleen size and extramedullary disease) and 3 genetic variables (cytogenetic, molecular and chimerism response) which serve to describe the heterogeneous picture of response to therapy in each individual case. It is hoped that these criteria will facilitate the comparison of results between clinical trials in juvenile myelomonocytic leukemia.

Published
2015

45. PONDx: real-life utilization and decision impact of the 21-gene assay on clinical practice in Italy

Author

Cognetti, Francesco, Masetti, Riccardo, Fabi, Alessandra, Bianchi, Giulia, Santini, Donatella, Rognone, Alessia, Catania, Giovanna, Angelucci, Domenico, Naso, Giuseppe, Giuliano, Mario, Vassalli, Lucia, Vici, Patrizia, Scognamiglio, Giovanni, Generali, Daniele, Zambelli, Alberto, Colleoni, Marco, Tinterri, Corrado, Scanzi, Francesco, Vigna, Leonardo, Scavina, Paola, Gamucci, Teresa, Marrazzo, Emilia, Scinto, Angelo Fedele, Berardi, Rossana, Fabbri, Maria Agnese, Pinotti, Graziella, Franco, Daniela, Terribile, Daniela Andreina, Tonini, Giuseppe, Cianniello, Daniela, and Barni, Sandro

Published
2021
Full Text
View/download PDF

49. Managing the Risk of Foodborne Infections in Pediatric Patients with Cancer: Is the Neutropenic Diet Still an Option?

Author

Pedretti, Laura, Leardini, Davide, Muratore, Edoardo, Capoferri, Gaia, Massa, Serena, Rahman, Sofia, Esposito, Susanna, and Masetti, Riccardo

Abstract

Infections pose a significant threat to morbidity and mortality during treatments for pediatric cancer patients. Efforts to minimize the risk of infection necessitate preventive measures encompassing both environmental and host-focused strategies. While a substantial number of infections in oncologic patients originate from microorganisms within their native microbiological environment, such as the oral cavity, intestines, and skin, the concrete risk of bloodstream infections linked to the consumption of contaminated food and beverages in the community cannot be overlooked. Ensuring food quality and hygiene is essential to mitigating the impact of foodborne illnesses on vulnerable patients. The neutropenic diet (ND) has been proposed to minimize the risk of sepsis during neutropenic periods. The ND aims to minimize bacterial entry into the gut and bacterial translocation. However, a standardized definition for ND and consensus guidelines for specific food exclusions are lacking. Most centers adopt ND during neutropenic phases, but challenges in achieving caloric intake are common. The ND has not demonstrated any associated benefits and does not ensure improved overall survival. Consequently, providing unified and standardized food safety instructions is imperative for pediatric patients undergoing hematopoietic cell transplantation (HCT). Despite the lack of evidence, ND is still widely administered to both pediatric and adult patients as a precautionary measure. This narrative review focuses on the impact of foodborne infections in pediatric cancer patients and the role of the ND in comparison to food safety practices in patients undergoing chemotherapy or HCT. Prioritizing education regarding proper food storage, preparation, and cooking techniques proves more advantageous than merely focusing on dietary limitations. The absence of standardized guidelines underscores the necessity for further research in this field. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results